Glycode
Uzerche
About Glycode
Glycode SAS, a biotechnology company, operates in the field of protein glycosylation in France. It provides and licenses GlycodExpress, a yeast based technological platform for the production of recombinant therapeutic glycoproteins for therapeutic purposes, such as antibodies, EPOs, and growth factors, as well as allows humanization of N-glycosylation in Saccharomyces cerevisiae. The company also offers on-demand production and purification services, from the conception and synthesis of optimized expression vectors for protein expression in glycoengineered yeasts to the early steps of production process. Glycode SAS serves biotechnology and pharmaceutical companies. The company was founded in 2004 and is based in Uzerche, France.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2010)
- Website: glycode.fr
- Phone: 33 5 55 73 77 19
Industries & Categories
Biopharma, Biotechnology, Medical Device
Canonical: https://fsome.com/organization/glycode-1557296 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.